Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Prostate Cancer Treatment and Research, PARP inhibition in cancer therapy, Cancer Immunotherapy and Biomarkers, and Cancer Genomics and Diagnostics.
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy
Structurally Oriented Classification of <i>FOXA1</i> Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes
Pan-Cancer Interrogation of B7-H3 ( <i>CD276</i> ) as an Actionable Therapeutic Target Across Human Malignancies
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type
Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
Use of class I histone deacetylase inhibitor romidepsin in combination regimens
Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma
Prostate Cancer Screening
A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer
Lenalidomide Monotherapy in Chemotherapy-Naive, Castration-Resistant Prostate Cancer Patients: Final Results of a Phase II Study